Shigella virulence protein VirG is a broadly protective antigen and vaccine candidate.

NPJ Vaccines · 2024 · PMC10761965 · PMID 38167387

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The VE was significantly higher in all vaccinated groups as compared to the negative control ( P < 0.001) but did not reach statistical significance when compared among VirGα vaccinated groups.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.